Evidence map›Paper›PMID 34831301›Full record

ReviewCells2021

Anissa Souidi, Krzysztof Jagla

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cells · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. EFFICIENT RIBOSOMAL RNA DEPLETION FROMWellcome open research · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Modelling phenotypes, variants and pathomechanisms of syndromic diseases in different systems.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  15. Pygo-F773W Mutation Reveals Novel Functions beyond Wnt Signaling inInternational journal of molecular sciences · 2024
    Article
  16. Review
  17. Drosophila as a Model to Understand Second Heart Field Development.Journal of cardiovascular development and disease · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Anissa SouidiGenetics Reproduction and Development Institute (iGReD), INSERM U1103, CNRS UMR6293, University of Clermont Auvergne, 28 Place Henri-Dunant, 63000 Clermont-Ferrand, France.
Krzysztof JaglaGenetics Reproduction and Development Institute (iGReD), INSERM U1103, CNRS UMR6293, University of Clermont Auvergne, 28 Place Henri-Dunant, 63000 Clermont-Ferrand, France.
Centre National de la Recherche Scientifique · FRUniversité Clermont Auvergne · FR

Funding

French Association against Myopathies AFM-Telethon grant
6 · The paper itself

Abstract

The

Indexed as

Disease Models, AnimalAgingAnimalsDrosophilaGene Expression Regulation, DevelopmentalHeartHeart DiseasesHumansarrhythmiacardiogenesisconduction defectscongenital cardiomyopathyDrosophila melanogasterheartmyotonic dystrophy type 1

Identifiers

PMID34831301
PMCPMC8623483
OpenAlexW3213208965

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.